
Jyothy Labs (JYOTHYLAB) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
6.7B
Gross Profit
3.3B
49.19%
Operating Income
973.9M
14.60%
Net Income
762.7M
11.44%
Balance Sheet Metrics
Total Assets
26.9B
Total Liabilities
6.4B
Shareholders Equity
20.5B
Debt to Equity
0.31
Cash Flow Metrics
Revenue & Profitability Trend
Jyothy Labs Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 28.5B | 27.5B | 24.8B | 22.0B | 19.1B |
Cost of Goods Sold | 14.2B | 14.2B | 14.5B | 12.9B | 10.2B |
Gross Profit | 14.3B | 13.4B | 10.4B | 9.0B | 8.9B |
Gross Margin % | 50.1% | 48.6% | 41.8% | 41.1% | 46.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 2.4B | 4.1B | 3.5B | 3.2B | 2.6B |
Other Operating Expenses | 3.6B | 1.2B | 911.8M | 753.1M | 668.0M |
Total Operating Expenses | 6.0B | 5.3B | 4.4B | 3.9B | 3.3B |
Operating Income | 4.4B | 4.3B | 2.7B | 1.9B | 2.6B |
Operating Margin % | 15.6% | 15.7% | 10.8% | 8.8% | 13.7% |
Non-Operating Items | |||||
Interest Income | - | 230.1M | 76.5M | 38.8M | 33.8M |
Interest Expense | 59.3M | 47.3M | 130.3M | 117.6M | 190.5M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 4.9B | 4.8B | 3.0B | 2.0B | 2.3B |
Income Tax | 1.2B | 1.1B | 594.9M | 377.9M | 439.8M |
Effective Tax Rate % | 24.2% | 22.9% | 19.9% | 19.2% | 18.7% |
Net Income | 3.7B | 3.7B | 2.4B | 1.6B | 1.9B |
Net Margin % | 13.0% | 13.4% | 9.7% | 7.2% | 10.0% |
Key Metrics | |||||
EBITDA | 5.6B | 5.2B | 3.4B | 2.7B | 3.3B |
EPS (Basic) | - | ₹10.06 | ₹6.53 | ₹4.41 | ₹5.43 |
EPS (Diluted) | - | ₹10.06 | ₹6.53 | ₹4.41 | ₹5.43 |
Basic Shares Outstanding | - | 367208644 | 367208644 | 367208644 | 367208644 |
Diluted Shares Outstanding | - | 367208644 | 367208644 | 367208644 | 367208644 |
Income Statement Trend
Jyothy Labs Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 771.8M | 843.9M | 1.1B | 760.2M | 718.6M |
Short-term Investments | 6.9B | 5.3B | 1.8B | 1.3B | 1.1B |
Accounts Receivable | 2.7B | 2.0B | 1.4B | 1.4B | 943.5M |
Inventory | 3.3B | 2.8B | 3.0B | 3.0B | 2.8B |
Other Current Assets | 466.6M | 325.0M | 441.0M | 596.1M | 541.9M |
Total Current Assets | 14.1B | 11.4B | 7.8B | 7.2B | 6.2B |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.5B | 242.4M | 232.6M | 209.7M | 196.7M |
Goodwill | 15.8B | 15.8B | 15.8B | 15.8B | 15.8B |
Intangible Assets | 62.7M | 54.5M | 61.2M | 39.3M | 47.1M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 524.1M | 419.1M | 437.1M | 512.9M | 567.8M |
Total Non-Current Assets | 12.8B | 12.6B | 12.9B | 13.0B | 13.3B |
Total Assets | 26.9B | 24.0B | 20.6B | 20.2B | 19.6B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 2.9B | 2.8B | 2.1B | 2.4B | 1.9B |
Short-term Debt | 247.6M | 246.5M | 185.3M | 1.5B | 1.4B |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.2B | 1.2B | 1.2B | 916.0M | 15.5M |
Total Current Liabilities | 5.1B | 4.8B | 4.1B | 5.2B | 4.7B |
Non-Current Liabilities | |||||
Long-term Debt | 365.2M | 259.1M | 280.0M | 244.9M | 291.8M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 34.6M | 40.3M | 55.2M | 70.1M | 22.9M |
Total Non-Current Liabilities | 1.3B | 1.1B | 1.0B | 991.4M | 925.6M |
Total Liabilities | 6.4B | 5.9B | 5.1B | 6.2B | 5.7B |
Equity | |||||
Common Stock | 367.2M | 367.2M | 367.2M | 367.2M | 367.2M |
Retained Earnings | - | 12.1B | 9.5B | 8.4B | 8.3B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 20.5B | 18.1B | 15.5B | 14.0B | 13.9B |
Key Metrics | |||||
Total Debt | 612.8M | 505.6M | 465.3M | 1.7B | 1.7B |
Working Capital | 9.0B | 6.6B | 3.7B | 2.0B | 1.5B |
Balance Sheet Composition
Jyothy Labs Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 4.9B | 4.8B | 3.0B | 2.0B | 2.3B |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 4.3M | 10.0M | 0 | - | - |
Working Capital Changes | -1.3B | -374.2M | 596.9M | -724.3M | 428.7M |
Operating Cash Flow | 3.4B | 4.2B | 3.6B | 1.3B | 3.2B |
Investing Activities | |||||
Capital Expenditures | -578.1M | -144.4M | -121.7M | -213.8M | -256.5M |
Acquisitions | - | - | - | - | 0 |
Investment Purchases | -17.1B | -13.6B | -21.8B | -131.6M | -1.0B |
Investment Sales | 15.9B | 10.1B | 21.4B | - | 0 |
Investing Cash Flow | -1.8B | -3.7B | -553.8M | -344.8M | -1.3B |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | -1.3B | -1.1B | -918.0M | -1.5B | - |
Debt Issuance | - | 0 | 50.0M | 2.3B | 2.3B |
Debt Repayment | - | 0 | -1.3B | -2.2B | -4.0B |
Financing Cash Flow | -1.3B | -1.1B | -3.4B | -1.3B | -2.7B |
Free Cash Flow | 2.5B | 4.2B | 2.9B | 1.8B | 3.8B |
Net Change in Cash | 299.1M | -531.9M | -343.2M | -307.4M | -858.5M |
Cash Flow Trend
Jyothy Labs Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
32.25
Forward P/E
64.44
Price to Book
5.83
Price to Sales
4.20
PEG Ratio
64.44
Profitability Ratios
Profit Margin
13.01%
Operating Margin
14.60%
Return on Equity
19.19%
Return on Assets
10.89%
Financial Health
Current Ratio
2.76
Debt to Equity
2.99
Beta
0.31
Per Share Data
EPS (TTM)
₹10.09
Book Value per Share
₹55.81
Revenue per Share
₹77.55
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
jyothylab | 119.6B | 32.25 | 5.83 | 19.19% | 13.01% | 2.99 |
Hindustan Unilever | 5.9T | 54.35 | 11.88 | 21.47% | 16.89% | 3.32 |
Godrej Consumer | 1.2T | 65.35 | 10.11 | 15.43% | 12.62% | 33.69 |
Honasa Consumer | 84.1B | 115.49 | 7.11 | 6.39% | 3.52% | 11.56 |
Marico | 912.5B | 54.65 | 22.92 | 38.19% | 14.58% | 12.99 |
Dabur India | 899.8B | 50.52 | 8.32 | 15.77% | 14.12% | 8.48 |
Financial data is updated regularly. All figures are in the company's reporting currency.